SEC Filings

Form 10-K
ORGANOVO HOLDINGS, INC. filed this Form 10-K on 05/31/2018
Document Outline
Entire Document (5027 KB)
Subdocument 1 - 10-K - 10-K
Page 1 - UNITED STATES
Page 2 - Organovo Holdings, Inc.
Page 3 - Important Information Regarding Forward-Looking Statements
Page 4 - PART I
Page 5 - Our Market Opportunity
Page 6 - The NovoGen Bioprinter Platform
Page 7 - Competition
Page 8 - In-Licensed IP
Page 9 - Regulatory Considerations
Page 10 - Available Information
Page 11 - We are an early-stage company with an unproven business strategy, and may never achieve profitabilit
Page 12 - We will require significant additional financing to support our long-term business plans.
Page 13 - If testing of a particular product candidate does not yield successful results, then we will be unab
Page 14 - Our technology, products and services are subject to the risks associated with new and rapidly evolv
Page 15 - We cannot control our collaborators allocation of resources or the amount of time that our collabora
Page 16 - We may have product liability exposure from the sale of our research tools and therapeutic products
Page 17 - We currently rely on third-party suppliers for some of our materials, including our supply of human
Page 18 - An inability to manage our growth or expansion of our operations could adversely affect our business
Page 19 - We are subject to risks associated with doing business outside the United States.
Page 20 - If restrictions on reimbursements and health care reform limit our or our collaborators actual or po
Page 21 - We use hazardous chemicals, biological materials and infectious agents in our business. Any claims r
Page 22 - We may be involved in lawsuits or other proceedings to protect or enforce our patents or the patents
Page 23 - We rely in part on trademarks to distinguish our products and services from those of other entities.
Page 24 - Investors may experience dilution of their ownership interests because of the future issuance of add
Page 25 - We do not intend to pay dividends for the foreseeable future.
Page 26 - PART II
Page 27 - Performance Graph
Page 28 - Item 6. Selected Financial Data (in thousands except per share data).
Page 29 - Item 7. Management s Discussion and Analysis of Financial Condition and Results of Operations.
Page 30 - Critical Accounting Policies
Page 31 - Research and development revenue under collaborative agreements
Page 32 - Product revenue
Page 33 - Fair Value Measurements
Page 34 - Costs and Expenses
Page 35 - Other Income (Expense)
Page 36 - Off-Balance Sheet Arrangements
Page 37 - Contractual Obligations
Page 38 - Item 8. Consolidated Financial Statements.
Page 39 - Report of Independent Registered Public Accounting Firm
Page 40 - Report of Independent Registered Public Accounting Firm
Page 41 - ORGANOVO HOLDINGS, INC.
Page 42 - ORGANOVO HOLDINGS, INC.
Page 43 - ORGANOVO HOLDINGS, INC.
Page 44 - ORGANOVO HOLDINGS, INC.
Page 45 - Supplemental Disclosure of Noncash Investing and Financing Activities ($ in thousands):
Page 46 - Organovo Holdings, Inc.
Page 47 - Use of estimates
Page 48 - Restricted cash
Page 49 - Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Page 50 - Revenue from research service agreements
Page 51 - Product revenue
Page 52 - Comprehensive income (loss)
Page 53 - 4. Derivative Liability
Page 54 - Preferred stock
Page 55 - N/A
Page 56 - Restricted stock units
Page 57 - Stock options
Page 58 - Common stock reserved for future issuance
Page 59 - Legal matters
Page 60 - Clemson University
Page 61 - 9. Concentrations
Page 62 - 10. Related Parties
Page 63 - 13. Quarterly Financial Data (unaudited)
Page 64 - Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
Page 65 - Inherent Limitations on Effectiveness of Controls
Page 66 - PART III
Page 67 - PART IV
Page 68 - EXHIBIT INDEX
Page 69 - N/A
Page 70 - SIGNATURES
Subdocument 2 - EX-23.1 - EX-23.1
Page 1 - N/A
Subdocument 3 - EX-31.1 - EX-31.1
Page 1 - N/A
Subdocument 4 - EX-31.2 - EX-31.2
Page 1 - N/A
Subdocument 5 - EX-32.1 - EX-32.1
Page 1 - N/A
XBRL Item - EX-101.INS - XBRL INSTANCE DOCUMENT (What's this?)
XBRL Item - EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA (What's this?)
XBRL Item - EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE (What's this?)
XBRL Item - EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE (What's this?)
XBRL Item - EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE (What's this?)
XBRL Item - EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE (What's this?)
XBRL Viewer
Print Page Print Page | E-mail Page Email Page | RSS Feeds RSS Feeds | IR Contacts Investor Contacts | Financial Tear Sheet Financial Tear Sheet